Authors: Frankovich, J Donaldson, SS Lee, YB Wong, RM Amylon, M Verneris, MR

Citation: J. Frankovich et al., High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: Atopy predicts idiopathic diffuse lung injury syndromes, BIOL BLOOD, 7(1), 2001, pp. 49-57

Authors: Shah, SJ Taub, JW Witt, TL Pollock, BH Ding, BC Moore, DS Amylon, M Pullen, J Ravindranath, Y Matherly, LH

Citation: Sj. Shah et al., Relationship of p15 and p16 gene alterations to elevated dihydrofolate reductase in childhood acute lymphoblastic leukaemia, BR J HAEM, 113(3), 2001, pp. 746-756

Authors: Laver, JH Barredo, JC Amylon, M Schwenn, M Kurtzberg, J Camitta, BM Pullen, J Link, MP Borowitz, M Ravindranath, Y Murphy, SB Shuster, J

Citation: Jh. Laver et al., Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report, LEUKEMIA, 14(3), 2000, pp. 369-373

Authors: Bennett, CL Stinson, TJ Lane, D Amylon, M Land, VJ Laver, JH

Citation: Cl. Bennett et al., Cost analysis of filgrastim for the prevention of neutropenia in pediatricT-cell leukemia and advanced lymphoblastic lymphoma: A case for prospective economic analysis in cooperative group trials, MED PED ONC, 34(2), 2000, pp. 92-96

Authors: Pullen, J Shuster, JJ Link, M Borowitz, M Amylon, M Carroll, AJ Land, V Look, AT McIntyre, B Camitta, B

Citation: J. Pullen et al., Significance of commonly used prognostic factors differs for children withT cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study, LEUKEMIA, 13(11), 1999, pp. 1696-1707

Authors: Abdel-Mageed, A Graham-Pole, J Del Rosario, MLU Longmate, J Ochoa, S Amylon, M Elfenbein, GJ Janiec, J Jansen, J Lazarus, HM

Citation: A. Abdel-mageed et al., Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants, BONE MAR TR, 23(9), 1999, pp. 929-932